Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,922.00
Bid: 2,928.00
Ask: 2,930.00
Change: -48.00 (-1.62%)
Spread: 2.00 (0.068%)
Open: 2,974.00
High: 2,974.00
Low: 2,918.00
Prev. Close: 2,970.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

24 Oct 2023 07:00

RNS Number : 0094R
Bunzl PLC
24 October 2023
 

24 October 2023

 

BUNZL Q3 TRADING STATEMENT

PROFIT IN-LINE WITH EXPECTATIONS; 2023 PROFIT OUTLOOK MAINTAINED

 

Bunzl plc, the specialist international distribution and services Group, today announces its trading statement for the period since 30 June 2023.

 

Following Bunzl's strong performance over recent years and continued resilience, the Group continues to perform well. Adjusted operating profit over the quarter was in-line with expectations and the Group reiterates its 2023 adjusted operating profit growth outlook.

 

Group revenue in the third quarter declined by 4.8% at constant exchange rates, with underlying revenue, which is organic growth adjusted for trading days, declining by 4.7%, driven by a continued decline in Covid-19 related product sales; a reduced level of inflation benefit; and wider post-pandemic related normalisation trends which drove expected volume weakness consistent with the prior quarter. One fewer trading day than the comparable period negatively impacted revenue by 0.8%1. Acquisitions contributed growth of 2.0% at constant exchange rates, whilst the disposal of our UK healthcare business impacted revenue by 1.3%. Overall, at actual exchange rates, given the weakness of sterling in the prior year, Group revenue declined by 8.8% over the quarter. Operating margin over the quarter was very strong, remaining substantially higher than compared to the pre-pandemic period in 2019, and slightly ahead of the Group's expectations.

 

We reiterate our confidence in the Group's 2023 adjusted operating profit being moderately higher than in 2022 at constant exchange rates. We expect Group revenue, at constant exchange rates, to be slightly lower than in 2022, with the benefit of announced acquisitions offset by some organic decline, following strong organic growth in recent years, and a small impact from the UK healthcare disposal. Operating margin in 2023 is now expected to reach the record level seen in recent years.

 

In September 2023, Bunzl signed an agreement to acquire CT Group, a distributor of surgical and medical devices and provider of value-added logistics services to health providers in Brazil which will enhance Bunzl's national presence and expand our product offering. In 2022, the higher margin business generated revenue of BRL 269 million (c.£42 million). Completion of the acquisition is subject to competition authority clearance.

 

Towards the end of August 2023, Bunzl completed the acquisition of Pittman Traffic & Safety Equipment in Ireland, a distributor of safety and asset protection solutions, such as bollards, speed bumps and workplace barriers. This acquisition supports the expansion of our North America based McCue business, which already has a UK presence. Pittman Traffic & Safety Equipment generated revenue of EUR 7 million (c.£6 million) in 2022.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Our performance continues to highlight the strength and resilience of the Group's business model, with revenue over the quarter 29% higher, and operating margin substantially higher, than the comparable period in 2019 at constant exchange rates. I remain confident in our ability to sustain a higher operating margin compared to pre-pandemic levels, supported by the acquisitions we have made over the period. Furthermore, today we announce our 13th and 14th acquisitions of 2023, with a total year-to-date committed spend of more than £425 million. I remain excited by the Group's medium-term opportunities, which continue to be driven by our proven compounding growth strategy and active acquisition pipeline, supported by a strong balance sheet."

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

 

Teneo

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

1. Net of the benefit of growth in excess of 26% per annum in hyperinflationary economies, largely in Turkey, which contributed a small increase of 0.1%.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUBDGIBDDGXX
Date   Source Headline
1st Apr 201511:22 amRNSDirector/PDMR Shareholding
1st Apr 201511:16 amRNSTotal Voting Rights
1st Apr 20159:11 amRNSHolding(s) in Company
27th Mar 20152:11 pmRNSHolding(s) in Company
27th Mar 201512:01 pmRNSAdditional Listing
20th Mar 201511:56 amRNSDirector/PDMR Shareholding
18th Mar 20154:34 pmRNSHolding(s) in Company
16th Mar 201511:48 amRNSHolding(s) in Company
12th Mar 201512:17 pmRNSAnnual Financial Report
11th Mar 201511:00 amRNSHolding(s) in Company
10th Mar 201512:11 pmRNSAdditional Listing
10th Mar 20159:43 amRNSDirector/PDMR Shareholding
6th Mar 20154:02 pmRNSDirector/PDMR Shareholding
6th Mar 201510:17 amRNSDirector/PDMR Shareholding
2nd Mar 20154:07 pmRNSDirector/PDMR Shareholding
2nd Mar 20153:35 pmRNSDirector/PDMR Shareholding
2nd Mar 20151:15 pmRNSTotal Voting Rights
27th Feb 201510:51 amRNSDirector/PDMR Shareholding
25th Feb 20153:38 pmRNSDirector/PDMR Shareholding
23rd Feb 201511:01 amRNSDividend Declaration
23rd Feb 20157:00 amRNSFinal Results
23rd Feb 20157:00 amRNSAcquisition
4th Feb 201512:06 pmRNSDirector/PDMR Shareholding
2nd Feb 201512:42 pmRNSTotal Voting Rights
21st Jan 20152:53 pmRNSDirector Declaration
21st Jan 201510:00 amRNSDirectorate Change
14th Jan 201511:45 amRNSDirector/PDMR Shareholding
6th Jan 20154:51 pmRNSDirector/PDMR Shareholding
6th Jan 20157:00 amRNSAcquisition
2nd Jan 20153:23 pmRNSTotal Voting Rights
16th Dec 20147:00 amRNSAdditional Listing
11th Dec 20147:00 amRNSTrading Statement
8th Dec 20141:55 pmRNSDirector/PDMR Shareholding
2nd Dec 20143:35 pmRNSDirector/PDMR Shareholding
1st Dec 201411:50 amRNSTotal Voting Rights
25th Nov 20144:48 pmRNSDirector/PDMR Shareholding
25th Nov 20144:33 pmRNSAdditional Listing
21st Nov 20144:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20144:16 pmRNSBlocklisting Interim Review
3rd Nov 20144:10 pmRNSTotal Voting Rights
22nd Oct 20145:16 pmRNSDirector/PDMR Shareholding
21st Oct 20145:41 pmRNSDirector/PDMR Shareholding
16th Oct 20147:00 amRNSInterim Management Statement
14th Oct 20144:57 pmRNSDirector/PDMR Shareholding
7th Oct 20144:58 pmRNSHolding(s) in Company
6th Oct 20143:18 pmRNSDirector/PDMR Shareholding
1st Oct 20143:44 pmRNSTotal Voting Rights
17th Sep 20147:00 amRNSAnalyst and Investor Presentation
9th Sep 20141:05 pmRNSDirector/PDMR Shareholding
5th Sep 20142:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.